Dexcom Q2 2026: revenue up 13.1%, EPS $0.64, guidance midpoint nudged up
Dexcom's second quarter was a clean beat: revenue of $1.3084 billion grew 13.1% and gross margin jumped to 63.4%, with GAAP EPS of $0.64 ahead of the $0.6229 consensus. The raised full-year revenue midpoint moved only $10 million, so the real news is margin, not top-line ambition. Read the guidance and balance-sheet sections before the headline growth number.
1 · Expected vs. Actual
Free preview belowGAAP diluted EPS of $0.64 beat the $0.6229 consensus by about 2.7%, and non-GAAP EPS of $0.70 compared with $0.48 a year ago. The gap between the two is real money: non-GAAP net income of $269.1 million excludes a $10.0 million loss from equity investments and $9.4 million of intangible amortization. Non-GAAP also leaves out $39.0 million of share-based compensation, which is a genuine cost to shareholders.
Revenue of $1.3084 billion rose 13.1% from $1.1571 billion a year ago and 9.8% from the $1.1919 billion booked in Q1 2026. Gross margin climbed to 63.4% from 59.5%, a 390 basis point improvement. That combination of faster sales and better margin is what drove operating income to $318.3 million, or 24.3% of revenue.
Management lifted the fiscal 2026 revenue midpoint to $5.215 billion, from $5.205 billion previously, and set the range at $5.18 to $5.25 billion. The margin outlook improved more: non-GAAP gross margin of approximately 64%, non-GAAP operating margin of approximately 23.5-24%. In other words, the guidance upgrade is mostly about profitability rather than a bigger sales number.
Log in to read 35 analyses a week for free
Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-09-17
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.